Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)
Not yet recruitingNCT07257380
Shanghai Zhongshan HospitalGastric / Gastroesophageal Junction Adenocarcinoma
Start: 2025-12-30End: 2029-12-30Target: 90Updated: 2025-12-02